Latest News and Press Releases

Retail Bank Executes Expanded $1.04M License Renewal for BIO-key Biometric Identity Solution Serving 30M Clients, cash position provides base for growth.

London, UK – 3 March, 2026 – Quell Therapeutics Ltd (“Quell”), a leader in developing engineered T-regulatory (Treg) cell therapies for serious medical conditions driven by the immune system, today...

ATLANTA, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator making fertility and non-surgical permanent birth control more accessible and cost-effective to...

MONAT Global Corp named World’s #1 Direct Seller of Premium Haircare by Euromonitor International

-- FemBloc becomes the latest Femasys product to achieve MDSAP certification, building on a proven track record of compliance -- ATLANTA, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ:...

Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025 ...

Amplify ETFs announces the Amplify CWP International Enhanced Dividend Income ETF (IDVO) has exceeded $1 billion in assets under management.

BIO-key (BKYI) & RunLevel Strengthen Identity Security for Mozambique’s National Payments Infrastructure for Sociedade Interbancária de Moçambique (SIMO).

-- Advances reimbursement strategy in the U.S. for FemaSeed, an intended first-step infertility treatment -- ATLANTA, Feb. 23, 2026 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading...

Q4 2025 revenue of $48.4 million, third consecutive quarter of sequential growthQ4 2025 Adjusted EBITDA* of $6.0 million and 12.4% margin and GAAP Net Income of $0.5 millionEliminated all outstanding...